Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma.

Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37220662

about

Considerations regarding current diagnosis and prognosis of hepatocellular carcinoma Transcatheter arterial chemoembolization: history for more than 30 years.Sorafenib and hepatic arterial infusion chemotherapy for unresectable advanced hepatocellular carcinoma: A comparative study Preoperative prognostic values of α-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in patients with hepatocellular carcinoma for living donor liver transplantation.Biological markers of hepatocellular carcinoma for use as selection criteria in liver transplantation.PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients.Recombinant snake venom prothrombin activators.Expression and characterization of recombinant ecarin.Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria.Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma.Impact of local tumor lesion treatments and preoperative indicators on the survival of patients with small hepatocellular carcinomas

P2860

Q28082223-69A5045E-4822-4D3D-9DB9-218E2B0E687F Q34642418-B7CE81D3-814E-4900-BBD8-6C113F66450C Q36230740-50995757-853F-4945-9107-5B9999D6CD51 Q37568646-86888526-7DE9-479B-9A88-EB1F88998778 Q38269467-552428F6-E135-4C42-A8CA-267615AFD255 Q38704682-235DDEA8-358F-4E5F-9E60-B2348FFE946A Q41316674-E72A04BB-1F9E-4DC1-BB94-E90532EFD262 Q42209746-B9FE8190-3EF5-4D49-974C-8DD0C9F9FECF Q42256347-C96A6274-6EBD-487A-BC76-5C2303A67118 Q43714851-1029CA4C-94B7-464C-BF49-3E66EB936BE1 Q58800852-D06B249D-2139-47DB-A467-7743E53D8F84

P2860

Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37220662

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Des-gamma-carboxy prothrombin ...... mall hepatocellular carcinoma.

@en

Des-gamma-carboxy prothrombin ...... mall hepatocellular carcinoma.

@nl

type

label

Des-gamma-carboxy prothrombin ...... mall hepatocellular carcinoma.

@en

Des-gamma-carboxy prothrombin ...... mall hepatocellular carcinoma.

@nl

prefLabel

Des-gamma-carboxy prothrombin ...... mall hepatocellular carcinoma.

@en

Des-gamma-carboxy prothrombin ...... mall hepatocellular carcinoma.

@nl

P1433

Q37220662-077AA930-2FB8-47C0-A9F8-12B66ECDDF78

P1476

Q37220662-E0B74105-B447-42C0-9781-20BB6B4D1C6A

P2093

Q37220662-18C8D509-C648-4C03-B0EF-1805862B39E0

Q37220662-1CA2E267-1571-4DDD-BF24-A5731D1E55F3

Q37220662-6CBC9FFA-C904-4960-970E-00E33418CC46

Q37220662-7AA6210A-F193-47CC-9C7E-F2060A3B8B66

Q37220662-83907573-8F9E-4085-B57A-D599C535259A

Q37220662-89E777FF-32C5-42C1-BD89-1F832DCD35B6

Q37220662-94577EBD-8E60-4702-9785-538C1F1711A8

Q37220662-C5EB0242-354E-489F-9293-B8D6E52D8B94

Q37220662-EBDE1F97-C2C1-47A2-A116-BD494014623C

P2860

Q37220662-032048CB-F1D5-4174-84CB-BA80021EBA7F

Q37220662-34995D19-D31E-4D99-BE14-9139653E59E1

Q37220662-3D46601A-9877-4E23-9BB6-1B6E0C5B20D4

Q37220662-3D651BD0-72E7-4283-A47C-3EF195E0D92F

Q37220662-60DFB5C8-2D76-4516-9E04-ABC105B598E8

Q37220662-62450146-EBA7-4F9C-89FE-8C3141C9492C

Q37220662-6E802D5A-FEA6-4C2C-91C2-EB42A0614BE7

Q37220662-75A3C774-7B24-4D31-8693-89BF63CC8782

Q37220662-8DEB7495-1A7B-4126-A87D-2706B79C7B4E

Q37220662-9123C50A-7FFB-43F8-A920-DA31FAB8894A

P304

Q37220662-49CB609C-DCB1-4C35-9AA1-F5ABAD32D83E

P31

Q37220662-C1A4BEF9-C8BE-4B2C-AA46-2C520131E437

P356

Q37220662-D9E7E534-D52F-46B7-BC97-9800B4D6A52A

P407

Q37220662-317901C3-9DF1-4DAB-B784-12E0A0F94598

P433

Q37220662-0FC0CFD7-D096-4CB1-8144-E7EB0CA9E679

P478

Q37220662-A3E21EE1-F54D-4533-B37C-710E39C83B66

P577

Q37220662-7A698A38-CEDE-4763-B1BA-0A82ACB3A8EF

P698

Q37220662-48F19EFB-1E9E-4283-97A2-A1840539CE7F

P932

Q37220662-1008301A-F5B0-402F-8FEB-7CC92E43EC19

P356

P1433

World Journal of Gastroenterology

P1476

Des-gamma-carboxy prothrombin ...... mall hepatocellular carcinoma.

@en

P2093

Hajime Morohashi

http://www.w3.org/2001/XMLSchema#string

Keinosuke Ishido

http://www.w3.org/2001/XMLSchema#string

Kenichi Hakamada

http://www.w3.org/2001/XMLSchema#string

Masaki Nara

http://www.w3.org/2001/XMLSchema#string

Mutsuo Sasaki

http://www.w3.org/2001/XMLSchema#string

Norihisa Kimura

http://www.w3.org/2001/XMLSchema#string

Shunji Narumi

http://www.w3.org/2001/XMLSchema#string

Takuya Miura

http://www.w3.org/2001/XMLSchema#string

Yoshikazu Toyoki

http://www.w3.org/2001/XMLSchema#string

P2860

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients.

Living-donor liver transplantation for hepatocellular carcinoma.

Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma.

Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation.

gamma-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-gamma-carboxy prothrombin.

Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review.

Survival and local recurrence rates of hepatocellular carcinoma patients treated by transarterial chemolipiodolization with and without embolization.

Clinicopathological characteristics of patients with extrahepatic recurrence following a hepatectomy for hepatocellular carcinoma.

P304

1370-1377

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.14.1370

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18322950

http://www.w3.org/2001/XMLSchema#string

P932

2693684

http://www.w3.org/2001/XMLSchema#string